834 related articles for article (PubMed ID: 10357920)
1. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
[TBL] [Abstract][Full Text] [Related]
2. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
Licht AH; Raab S; Hofmann U; Breier G
Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
[TBL] [Abstract][Full Text] [Related]
4. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
Dacquin R; Starbuck M; Schinke T; Karsenty G
Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
[TBL] [Abstract][Full Text] [Related]
5. Development of a transgenic mouse model using rat insulin promoter to drive the expression of CRE recombinase in a tissue-specific manner.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Int J Pancreatol; 1999 Jun; 25(3):157-63. PubMed ID: 10453417
[TBL] [Abstract][Full Text] [Related]
6. Specific Cre/Lox recombination in the mouse proximal tubule.
Rubera I; Poujeol C; Bertin G; Hasseine L; Counillon L; Poujeol P; Tauc M
J Am Soc Nephrol; 2004 Aug; 15(8):2050-6. PubMed ID: 15284291
[TBL] [Abstract][Full Text] [Related]
7. Alterations of pancreatic beta-cell mass and islet number due to Ins2-controlled expression of Cre recombinase: RIP-Cre revisited; part 2.
Pomplun D; Florian S; Schulz T; Pfeiffer AF; Ristow M
Horm Metab Res; 2007 May; 39(5):336-40. PubMed ID: 17533574
[TBL] [Abstract][Full Text] [Related]
8. A transgenic mouse that targets the expression of Cre recombinase in pancreatic tissue.
Zhou J; Cheng X; Lu YX; Huang CF; Yang X
Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):286-90. PubMed ID: 12192858
[TBL] [Abstract][Full Text] [Related]
9. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.
Utomo AR; Nikitin AY; Lee WH
Nat Biotechnol; 1999 Nov; 17(11):1091-6. PubMed ID: 10545915
[TBL] [Abstract][Full Text] [Related]
10. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision.
Novak A; Guo C; Yang W; Nagy A; Lobe CG
Genesis; 2000; 28(3-4):147-55. PubMed ID: 11105057
[TBL] [Abstract][Full Text] [Related]
11. Z/AP, a double reporter for cre-mediated recombination.
Lobe CG; Koop KE; Kreppner W; Lomeli H; Gertsenstein M; Nagy A
Dev Biol; 1999 Apr; 208(2):281-92. PubMed ID: 10191045
[TBL] [Abstract][Full Text] [Related]
12. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
Kisanuki YY; Hammer RE; Miyazaki J; Williams SC; Richardson JA; Yanagisawa M
Dev Biol; 2001 Feb; 230(2):230-42. PubMed ID: 11161575
[TBL] [Abstract][Full Text] [Related]
13. Generation of oocyte-specifically expressed cre transgenic zebrafish for female germline excision of loxP-flanked transgene.
Liu X; Li Z; Emelyanov A; Parinov S; Gong Z
Dev Dyn; 2008 Oct; 237(10):2955-62. PubMed ID: 18816824
[TBL] [Abstract][Full Text] [Related]
14. A novel transgenic technique that allows specific marking of the neural crest cell lineage in mice.
Yamauchi Y; Abe K; Mantani A; Hitoshi Y; Suzuki M; Osuzu F; Kuratani S; Yamamura K
Dev Biol; 1999 Aug; 212(1):191-203. PubMed ID: 10419695
[TBL] [Abstract][Full Text] [Related]
15. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
Gelman DM; NoaĆn D; Avale ME; Otero V; Low MJ; Rubinstein M
Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
Jin C; McKeehan K; Wang F
Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
[TBL] [Abstract][Full Text] [Related]
18. Cre-loxP system as a versatile tool for conferring increased levels of tissue-specific gene expression from a weak promoter.
Nakamura S; Watanabe S; Ohtsuka M; Maehara T; Ishihara M; Yokomine T; Sato M
Mol Reprod Dev; 2008 Jun; 75(6):1085-93. PubMed ID: 18163444
[TBL] [Abstract][Full Text] [Related]
19. Production of CETD transgenic mouse line allowing ablation of any type of specific cell population.
Sato M; Tanigawa M
Mol Reprod Dev; 2005 Sep; 72(1):54-67. PubMed ID: 15902717
[TBL] [Abstract][Full Text] [Related]
20. Unexpected functional consequences of xenogeneic transgene expression in beta-cells of NOD mice.
Leiter EH; Reifsnyder P; Driver J; Kamdar S; Choisy-Rossi C; Serreze DV; Hara M; Chervonsky A
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():14-22. PubMed ID: 17919174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]